<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02739399</url>
  </required_header>
  <id_info>
    <org_study_id>MM2015.037</org_study_id>
    <nct_id>NCT02739399</nct_id>
  </id_info>
  <brief_title>Effects of Phenylephrine on Cardiac Preload</brief_title>
  <official_title>The Dynamic Effects of Phenylephrine on Preload and Cardiac Output in Patients Under General Anaesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Algemeen Ziekenhuis Maria Middelares</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Algemeen Ziekenhuis Maria Middelares</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In patients under general anesthesia, episodes of hypotension are often treated with
      phenylephrine. The effect of phenylephrine is conventionally attributed to afterload
      increase.

      The aim of the study is to describe the time course of the effects of phenylephrine on the
      cardiac preload and cardiac output, and to evaluate whether phenylephrine, as an exclusive
      alpha-mimetic, could be beneficial for preload optimisation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In consecutive patients scheduled for laparoscopic sigmoidectomy, all hemodynamic and
      respiratory variables are recorded electronically for subsequent offline analysis.

      All patients are ventilated in volume control mode with a tidal volume of 8 ml/kg ideal body
      weight.

      During steady-state Target Controlled Infusion (TCI) propofol/remifentanil anesthesia, when
      the Mean Arterial Blood Pressure (MAP) dropped below 80% of the awake state for at least 5
      minutes, a phenylephrine bolus of 2 μg/kg is administered. If necessary this is repeated, or
      a continuous administration of phenylephrine is started at a rate of 10-30 μg/kg/u.

      All patient manipulations during the procedure are electronically recorded and time stamped
      for subsequent off-line data analysis.

      The first episode in each patient where phenylephrine is administered and in a period of at
      least 10 minutes when minimal or absent patient manipulation occurred, the hemodynamic
      variables are analysed to describe the effects of phenylephrine administration on the dynamic
      preload parameters and macro-hemodynamics.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2016</start_date>
  <completion_date type="Actual">September 2016</completion_date>
  <primary_completion_date type="Actual">July 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiac output</measure>
    <time_frame>perioperative</time_frame>
    <description>The evolution of the Cardiac Output in a time course &lt;20 minutes after administration</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pulse Pressure Variation</measure>
    <time_frame>perioperative</time_frame>
    <description>The evolution of Pulse Pressure Variation in a time course &lt;20 minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>End-Tidal CO2</measure>
    <time_frame>perioperative</time_frame>
    <description>The evolution of the EtCO2-value in a time course &lt;20 minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arterial Blood Pressure</measure>
    <time_frame>perioperative</time_frame>
    <description>The evolution of The Arterial Blood Pressure in a time course &lt;20 minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>central venous pressure</measure>
    <time_frame>perioperative</time_frame>
    <description>The evolution of the central venous pressure in a time course &lt;20 minutes</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Arterial Hypotension</condition>
  <condition>Anaesthesia</condition>
  <arm_group>
    <arm_group_label>Patient receiving phenylephrine 2ug/kg</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>phenylephrine 2ug/kg in case of hypotension</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Phenylephrine</intervention_name>
    <description>Intravenous administration</description>
    <arm_group_label>Patient receiving phenylephrine 2ug/kg</arm_group_label>
    <other_name>Phenyl</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult

          -  necessity for arterial blood pressure monitoring

          -  necessity for central venous blood pressure monitoring

        Exclusion Criteria:

          -  unwilling or unable to grant written informed consent

          -  cardiac arrythmia

          -  contra-indication for phenylephrine

          -  contra-indications for atropine

          -  contra-indication for Total Intravenous Anesthesia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alain F Kalmar, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anaesthesiology and Intensive care medicine, Maria Middelares hospital, Ghent, Belgium</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>AZ Maria Middelares</name>
      <address>
        <city>Gent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 6, 2016</study_first_submitted>
  <study_first_submitted_qc>April 11, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 15, 2016</study_first_posted>
  <last_update_submitted>December 8, 2016</last_update_submitted>
  <last_update_submitted_qc>December 8, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 9, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Algemeen Ziekenhuis Maria Middelares</investigator_affiliation>
    <investigator_full_name>Dr. Alain Kalmar, MD, PhD</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>phenylephrine</keyword>
  <keyword>alpha mimetics</keyword>
  <keyword>pulse pressure variation</keyword>
  <keyword>venous return</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypotension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Phenylephrine</mesh_term>
    <mesh_term>Oxymetazoline</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

